You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Haloperidol lactate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for haloperidol lactate and what is the scope of freedom to operate?

Haloperidol lactate is the generic ingredient in four branded drugs marketed by Ortho Mcneil, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Rubicon, SCS, Teva, Teva Pharms, Hikma, Janssen Pharms, Abraxis Pharm, Baxter Hlthcare Corp, Epic Pharma Llc, Fosun Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Smith And Nephew, Solopak, Teva Pharms Usa, Watson Labs, and Actavis Mid Atlantic, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

Fourteen suppliers are listed for this compound.

Summary for haloperidol lactate
US Patents:0
Tradenames:4
Applicants:25
NDAs:34
Finished Product Suppliers / Packagers: 14
Raw Ingredient (Bulk) Api Vendors: 7
Clinical Trials: 5
Patent Applications: 297
What excipients (inactive ingredients) are in haloperidol lactate?haloperidol lactate excipients list
DailyMed Link:haloperidol lactate at DailyMed
Drug Sales Revenue Trends for haloperidol lactate

See drug sales revenues for haloperidol lactate

Recent Clinical Trials for haloperidol lactate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Christian HassagerPhase 3
Services Institute of Medical Sciences, PakistanPhase 1
University Hospital, Basel, SwitzerlandPhase 4

See all haloperidol lactate clinical trials

Pharmacology for haloperidol lactate
Anatomical Therapeutic Chemical (ATC) Classes for haloperidol lactate

US Patents and Regulatory Information for haloperidol lactate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 091637-001 Sep 2, 2011 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 076791-001 Aug 25, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 076828-001 Aug 25, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Scs HALOPERIDOL haloperidol lactate CONCENTRATE;ORAL 070726-001 Jun 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 075689-001 Mar 9, 2001 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol lactate CONCENTRATE;ORAL 015922-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for haloperidol lactate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol lactate CONCENTRATE;ORAL 015922-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Janssen Pharms HALDOL haloperidol lactate INJECTABLE;INJECTION 015923-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.